Skip to search formSkip to main contentSkip to account menu

amfenac

Known as: 2-amino-3-benzoylbenzeneacetic acid, monosodium salt, monohydrate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
To evaluate the effects of topical non‐steroidal anti‐inflammatory drugs (NSAIDs) on retinal vascular leakage, and inflammatory… 
2014
2014
PurposeUnder conditions of oxidative stress, cell apoptosis is triggered through the mitochondrial intrinsic pathway. Increased… 
Review
2013
Review
2013
OBJECTIVE: To examine the efficacy of nepafenac in the treatment of pain and inflammation in patients after cataract surgery… 
Highly Cited
2008
Highly Cited
2008
The removal of diclofenac sodium ophthalmic solution as a viable pharmaceutical entity in September 1999 from the US market… 
2008
2008
PurposeTo evaluate the proliferation rates of five human uveal melanoma (UM) cell lines after treatment with amfenac, a… 
Highly Cited
2000
Highly Cited
2000
Nepafenac, the amide analog of the NSAID amfenac, was examined in vitro for its bioactivation by ocular tissue components and its… 
1990
1990
A series of potential prodrugs of 2-amino-3-benzoylbenzeneacetic acid (amfenac) and 2-amino-3-(4-chlorobenzoyl)benzeneacetic acid… 
1986
1986
Amfenac, an arylacetic acid derivative, is a new investigational, nonsteroidal antiinflammatory agent that has exhibited…